Correlation Between Eli Lilly and ArriVent BioPharma,
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and ArriVent BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and ArriVent BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and ArriVent BioPharma, Common, you can compare the effects of market volatilities on Eli Lilly and ArriVent BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of ArriVent BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and ArriVent BioPharma,.
Diversification Opportunities for Eli Lilly and ArriVent BioPharma,
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eli and ArriVent is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and ArriVent BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ArriVent BioPharma, and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with ArriVent BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ArriVent BioPharma, has no effect on the direction of Eli Lilly i.e., Eli Lilly and ArriVent BioPharma, go up and down completely randomly.
Pair Corralation between Eli Lilly and ArriVent BioPharma,
Considering the 90-day investment horizon Eli Lilly is expected to generate 1.92 times less return on investment than ArriVent BioPharma,. But when comparing it to its historical volatility, Eli Lilly and is 1.88 times less risky than ArriVent BioPharma,. It trades about 0.07 of its potential returns per unit of risk. ArriVent BioPharma, Common is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 1,800 in ArriVent BioPharma, Common on September 14, 2024 and sell it today you would earn a total of 872.00 from holding ArriVent BioPharma, Common or generate 48.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 83.64% |
| Values | Daily Returns |
Eli Lilly and vs. ArriVent BioPharma, Common
Performance |
| Timeline |
| Eli Lilly |
| ArriVent BioPharma, |
Eli Lilly and ArriVent BioPharma, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eli Lilly and ArriVent BioPharma,
The main advantage of trading using opposite Eli Lilly and ArriVent BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, ArriVent BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArriVent BioPharma, will offset losses from the drop in ArriVent BioPharma,'s long position.| Eli Lilly vs. Johnson Johnson | Eli Lilly vs. Bristol Myers Squibb | Eli Lilly vs. AbbVie Inc | Eli Lilly vs. Pfizer Inc |
| ArriVent BioPharma, vs. Puma Biotechnology | ArriVent BioPharma, vs. Iovance Biotherapeutics | ArriVent BioPharma, vs. Day One Biopharmaceuticals | ArriVent BioPharma, vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |